FindTrial
Sign In

Improving The Success Rate in IVF Process Using Mothers Own Blood Fluid

The Effect of Doping Autologous Blood Plasma in Growth Media for Achieving Higher Success Rate in IVF

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/043718
Enrollment
250
Registered
2022-07-05
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O029- Abnormal product of conception, unspecified Health Condition 2: O038- Other and unspecified complications following complete or unspecified spontaneous abortion

Interventions

Intervention1: Topical Application: Topical application of autologous blood plasma on the endometrium layer inside uterine cavity by IUI catheter Dose: 1 ml autologous plasma per shot. Frequency: On

Sponsors

STEMBIONICS PVT LTD
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: At least one implantation failure in IVF.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pregnancy positiveTimepoint: 3 months—

Secondary

MeasureTime frame
1. Observation of implanted zygote 2. Qualitative analysis of implanted zygote Timepoint: 3 months—

Countries

India

Contacts

Public ContactManibrata Paul

AHIVF and IRC

manibratapaul@gmail.com9830061141

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026